We can buy this stock at 0,15$, Atreca Inc is a company created in United States dedicated to Biotechnology: Pharmaceutical Preparations with its highest number of sales in North America. Its Executives are Daniel Emerling (Senior Vice President-Research), Herbert C. Cross (Chief Financial Officer), John A. Orwin (President, Chief Executive Officer & Director), Jonathan Benjamin (Vice President-Clinical Research), Wayne Volkmuth (SVP-Informatics & Information Technology) and its address is 450 EAST JAMIE COURT, SOUTH SAN FRANCISCO, California, 94080, United States.
The closing price of the stock yesterday was desconocido$.
The current range on the same day is from 0,15$ - 0,19$, with a percentage difference of 0,17$ quite wide that helps to be able to do day trading.
Their latest annual data shows an income of desconocido.
The opening price that appears as last recorded is desconocido.
To detect if it is a good time to enter or exit a stock, many traders use the lowest and highest values of the last 52 weeks. In this action, prices have moved between 0,00$ and 0,00$.
EPS is the net profit that the company has obtained, after paying taxes, divided by the number of total shares it has in circulation. This value is higher the better the company has done, although with some nuances since it can increase if the number of shares for sale decreases, or it can decrease if things that have happened in just a few months are charged annually. For this action the BPA is [BPA].